Skip to content
GenoLensGenoLens

GNB2

Chr 7q22.1

G protein subunit beta 2

MANE:
ENST00000303210.9

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Mosaic skin disorders - deep sequencing

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • neurodevelopmental disorder with hypotonia and dysmorphic facies

    0.69
  • familial sick sinus syndrome

    0.52
  • complex neurodevelopmental disorder

    0.37
  • hereditary disease

    0.34
  • Global developmental delay

    0.27
  • Sturge-Weber syndrome

    0.19
  • inflammatory bowel disease

    0.12
  • schizophrenia

    0.09
  • colorectal carcinoma

    0.09
  • acute myeloid leukemia

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2

Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.